NEXT GENERATION FERTILITY TECH
Separating Winning
Sperm in Alliance
with Nature
ABOUT
Molecule 46
Molecule 46 Ltd. is a biotech spin-off offering a unique patented technology for the diagnostic and separation of undamaged sperm, delivering a revolutionary solution to human infertility through assisted reproduction and enhanced livestock breeding with high-quality insemination doses.
The technology, based on the principles of natural fertilization, selects sperm with an intact acrosome, undamaged DNA, and progressive motility — increasing success rates of assisted reproduction methods including ICSI. It also enables freezing of selected sperm, benefiting infertile men, oncology patients, and healthy men in preventive sperm banking programs.
The company brings an innovative approach with a strong IP position and robust scientific research. The clear regulatory pathway is strengthened by an internationally recognised founder with a strong academic track record and proven founder/market fit for a large and fast-growing market. The technology further extends to livestock breeding, enabling high-quality insemination doses and in vitro embryo production for embryo transfer.
This project offers real social impact as well as endorsement from buyers and users.
HUMAN
Application
ASSISTED REPRODUCTION
Increase of sperm quality
and fertilization success
CRYOPRESERVATION
Sperm banking for medical and personal fertility preservation
SOCIAL FREEZING
Sperm banking for
long-term reproductive planning
ONCOFERTILITY
Personalised approach
to oncology patients
PREVENTIVE MEDICINE
Diagnostic and screening
of reproductive health
ANIMAL
Application
LIVESTOCK BREEDING
Healthy sperm for
efficient insemination
ENDANGERED SPECIES CONSERVATION
Undamaged sperm for
ZOO-based fertility programs
HUMAN
Application
ASSISTED
REPRODUCTION
Increase of sperm quality
and fertilization success
CRYOPRESERVATION
Sperm banking for medical and personal fertility preservation
SOCIAL FREEZING
Sperm banking for long-term reproductive planning
ONCOFERTILITY
Personalised approach
to oncology patients
PREVENTIVE MEDICINE
Diagnostic and screening
of reproductive health
ANIMAL
Application
LIVESTOCK BREEDING
Healthy sperm for
efficient insemination
ENDANGERED SPECIES
CONSERVATION
Undamaged sperm for
ZOO-based fertility
programs
SUCCESS to date
STRONG IP POSITION
AND PROACTIVE IP STRATEGY
- Exclusive rights to core IP assets
- Czech and European patents granted
- New PCT applications in preparation
- US patent application pending
- European trademark registered
TRACTION & PROOF OF MARKET
- 15+ years of underlying scientific research
- Successful in vitro benchmarking studies completed
- Two prototype iterations leading to MVP 2.0
- Molecule 46 Sperm Separation Technology at TRL 4
- Validation and endorsement from seven leading IVF clinics
- Partnerships with three leading European livestock breeding companies
- First paying customers in the animal reproduction market
- 20+ qualified early-adopter opportunities in the pipeline
LOCAL & INTERNATIONAL
NON-DILUTIVE FUNDING
- CzechInvest Technology Incubation Program
- Central Bohemian Innovation Center (SIC)
- EIT Health
- European and US technology grant applications under review (€1M+)
PEOPLE
- Scientific Advisory Board established, including a Nobel Prize Laureate
- Multidisciplinary R&D team in place
- Strategic hires identified to support commercialization and growth
AWARDS and MEDIA
2026
EU Seal of Excellence, Horizon Europe,
EIC pre-accelerator – Widening
Creative Heroes Award Czech Republic,
Category 1:1,000,000,000 – Impact on an International Scale
2025
Winner of the InnoStars Awards EIT Health
Bronze Award at Company of the Year, Capital City Prague
Silver Award at Start-up Disrupt Innovations United
Innovations United, Key-note and panellist
2024
Gold Award at Start-up Accelerator,
Central Bohemian Innovation Center
Forbes, The most influential women of the Czech Republic
Forbes, Invited speaker at The Next Big Thing
Nominated for The Czech Scientist
of the Year – Innovation Technology
and EY Entrepreneur of the Year
2023
Forbes, Top Czech women scientist 2023
Ministry of Foreign Affairs, Czech women in World Science, TV and newspaper coverage, Czech Consulate, Istanbul, Turkey
2022
The Guardian, The Telegraph, BBC Science focus, Daily Mirror, The Tribune, Yahoo news
Czech TV, Prima CNN, Czech Radio,
and newspaper coverage
Czech Grant agency award for outstanding grant achievement
2021
Czech Press Office release,
The utilization of CD46 protein can accelerate the process of artificial insemination.
2025
Winner of the InnoStars Awards EIT Health
Bronze Award at Company of the Year, Capital City Prague
Silver Award at Start-up Disrupt Innovations United
Innovations United, Key-note and panellist
2023
Forbes, Top Czech women scientist 2023
Ministry of Foreign Affairs, Czech women in World Science, TV and newspaper coverage, Czech Consulate, Istanbul, Turkey
2021
Czech Press Office release,
The utilization of CD46 protein can accelerate the process of artificial insemination.
PROUD to cooperate with
